Design of Mycobacterium tuberculosis thymidine monophosphate kinase inhibitors.
Munier-Lehmann
H
H
Laboratoire de Chimie Structurale des Macromolécules, URA CNRS 2185, Institut Pasteur, Paris Cedex, France. hmunier@pasteur.fr
Pochet
S
S
Dugue
L
L
Dutruel
O
O
Labesse
G
G
Douget
D
D
D000995:Antitubercular Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D001665:Binding Sites; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology; D004926:Escherichia coli / Q000201:enzymology; D006801:Humans; D007202:Indicators and Reagents; D009169:Mycobacterium tuberculosis / Q000201:enzymology*; D009703:Nucleoside-Phosphate Kinase / Q000037:antagonists & inhibitors* / Q000737:chemistry; D012441:Saccharomyces cerevisiae / Q000201:enzymology; D013936:Thymidine / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000494:pharmacology
D000995:Antitubercular Agents; D004791:Enzyme Inhibitors; D007202:Indicators and Reagents; D009703:Nucleoside-Phosphate Kinase; C020093:dTMP kinase; D013936:Thymidine